TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Jun 25, 2019 19:00 JST
Source:
Hacarus Inc.
DS Pharma Animal Health awards Hacarus the Grand Prize for 'New Business Solutions in Animal Health'
KYOTO, Japan, Jun 25, 2019 - (JCN Newswire) - Hacarus Inc, the leading provider of lightweight and explainable AI, was today awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform 'HACARUS.ai'.
"It is a great honor to receive this award for our work in creating technology that will improve animals' lives. Together with DS Pharma, we see a great opportunity to revolutionize animal health diagnostics with our AI technology, making treatment safer, faster and more humane," said Kenshin Fujiwara, CEO and Founder of Hacarus.
DS Pharma Animal Health is Japan's largest provider of animal health services, supporting some 11,000 animal hospitals and veterinarian clinics throughout the nation. It is also a market leader in the fields of companion animal-, livestock- and fisheries businesses. Through its 'New Business Search Program to Support Animal Health', DS Pharma is focused on finding the best leading-edge services and technologies that will help propel animal health, diagnostics and maintenance into the next century.
Amongst 18 project proposals shortlisted for innovation, impact and business potential, Hacarus was awarded the Grand Prize. The collaboration, aimed at bringing Hacarus Sparse Modeling-based AI tools to animal health diagnostics, sees DS Pharma and Hacarus working together on both a proprietary medical device and accompanying cloud services. Following a successful initial phase, the two companies will proceed towards a commercial partnership to provide AI enhanced animal health diagnostics in Japan and beyond.
About DS Pharma Animal Health Co., Ltd.
DS Pharma Animal Health is an R&D company established in July 2010 as a separate company from the business division of Sumitomo Dainippon Pharma Co., Ltd. Based on the experience and results gained through more than 70 years in the animal medicine business the company manufactures and markets pharmaceutical products for animals. In addition to medicines and functional foods, the company is expanding its business domain to the entire veterinary healthcare cycle - examinations, diagnoses, medicines and aftercare - and promoting transformation into a company that provides smart solutions. Please visit
https://animal.ds-pharma.co.jp/
.
About Hacarus
Hacarus Inc, founded in 2014 in Kyoto, Japan is the leading provider of explainable lightweight AI tools, backed by Miyako Capital (Kyoto University), among others. Its solutions are used in the medical and manufacturing fields to enable humans to make better, faster and more reliable decisions based on AI-driven insights. Hacarus' proprietary AI engine is built using 'Sparse Modeling', an AI method that understands data like a human would - by its unique key features - and is far more resource, time and energy efficient when compared to 'Deep Learning'. Please visit
https://hacarus.com
.
Source: Hacarus Inc.
Sectors: Healthcare & Pharm, Automation [IoT]
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Press Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
Honda Unveils Next-generation EV Series for China
Apr 17, 2024 12:15 JST
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST
Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST
More Latest Release >>